Opendata, web and dolomites

SAL ETHVI

Innovative, easily applicable vaccine for poultry industry against five Salmonella serovars: Enteritidis, Typhimurium, Hadar, Virchow and Infantis – SAL ETHVI

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SAL ETHVI project word cloud

Explore the words cloud of the SAL ETHVI project. It provides you a very rough idea of what is the project "SAL ETHVI" about.

intervention    owners    virchow    listed    typhimurium    frequently    2003    configuration    spreading    patent    critical    flocks    markets    russia    commercialize    zoonotic    united    poland    despite    germany    plan    serovars    sources    registration    competitive    netherlands    infections    gastrointestinal    disease    market    hadar    vaccination    meat    performed    feasibility    breakthrough    poisoning    infantis    levels    broilers    sal    species    lower    mapping    human    serotypes    sme    invented    complete    france    vaccines    innovative    ethvi    hens    filled    chickens    chicken    risks    chain    constituting    certification    biggest    78    bacteria    producers    breeders    risk    activation    industry    food    serovar    ultimately    farms    business    worldwide    kingdom    vaccine    instrument    rates    hatching    animals    salmonella    reduce    contaminated    places    poultry    safer    sizing    strategy    humans    price    comprise    adventage    pathogens    enteritidis    biosecurity    immunolab   

Project "SAL ETHVI" data sheet

The following table provides information about the project.

Coordinator
ZAKLAD BADAWCZO-WDROZENIOWY OSRODKASALMONELLA IMMUNOLAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA 

Organization address
address: UL. AL. ZWYCIESTWA 96/98
city: GDYNIA
postcode: 81 451
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Project website http://immunolab.com.pl/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.3.2. (SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2016-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ZAKLAD BADAWCZO-WDROZENIOWY OSRODKASALMONELLA IMMUNOLAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA PL (GDYNIA) coordinator 50˙000.00
2    NatVet sp. z o. o. PL (Gdansk) participant 0.00

Map

 Project objective

Salmonella species (also called serovars) are important zoonotic pathogens that cause gastrointestinal disease in humans and animals. Poultry products contaminated with these pathogens are one of the major sources of human Salmonella infections worldwide. Salmonella Enteritidis and Typhimurium are the serovars most frequently associated with human food poisoning (78.3 % of all cases in 2003). The serovars of Salmonella having places three to five are Virchow, Infantis and Hadar. Vaccination of chickens, along with other intervention measures in the overall biosecurity system of chicken farms, is an important strategy that is currently being used to reduce the levels of Salmonella in poultry flocks, which will ultimately lead to lower rates of human infections. However, despite numerous studies that have been performed, there is still a need for safer, well-defined Salmonella vaccines. At Immunolab we invented SAL ETHVI – innovative vaccine against above listed 5 serovars of Salmonella. We also breakthrough the technology for the vaccine production in a way that allows any configuration of serotypes, therefore if there is a need for a vaccine against another serovar, its production will be very easy. The end users of the vaccine will be poultry breeders, namely hens and broilers flocks owners. The unique features of our vaccine constituting our competitive adventage comprise : (1) easy application ; (2) low price ; (3) immediate vaccination upon hatching; (4) no risk of bacteria activation and spreading. We have filled a patent application for the technology and upon the vaccine registration and certification, we aim to commercialize it at the broilers markets of the biggest European poultry meat producers: Poland, Germany, France, the Netherlands, United Kingdom and Russia. We are applying for the SME Instrument Phase 1, aiming to complete the feasibility study and a business plan including industry value-chain mapping, market sizing and critical risks assessment.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAL ETHVI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAL ETHVI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.3.2.)

MycoQuest (2015)

Rapid on-site detection of Mycotoxin in wheat

Read More  

PROTECTDAIRY-F2F (2015)

Eco-innovative and fully integrated microbial rapid monitoring system - PROTECTING shelf life, food safety and quality throughout the DAIRY supply chain, from farm to fork.

Read More  

CHAMPIPACK (2016)

Active packaging for extending lifespan of champignon

Read More